NCCR-Synapsy

The Synaptic Bases of Mental Diseases

NEWS & AWARDS

ALL SYNAPSY'S NEWS

JUMP TO A SPECIFIC MONTH
From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders
Mood disorders Newsletter

From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders

We spoke with Charles Finsterwald, PhD, Chief Scientific Officer and co-founder of the start-up Gliapharm about his career path and his decision to switch from fundamental research to application.An interest...
Read More
Lactate, a prospect for the treatment of depression
Mood disorders Newsletter

Lactate, a prospect for the treatment of depression

According to WHO, more than 264 million people in the world suffer from depression, a disorder that has a major impact on all facets of the lives of those it...
Read More
Holography and cellular reprogramming in the quest for biomarkers
Mood disorders Newsletter

Holography and cellular reprogramming in the quest for biomarkers

Bipolar disorders affect some 2% of the population. Patients present a wide variety of clinical symptoms of which many can be especially handicapping. A new approach to find biomarkers, driven...
Read More
A career at the intersection of physics and psychiatry
Mood disorders Newsletter

A career at the intersection of physics and psychiatry

Pierre Marquet’s career path has been rather untypical. Combining qualifications in physics and psychiatry-psychotherapy, he is a clinical researcher “par excellence”, engaged for over 20 years in the development of...
Read More
From science to yoga — and back to science
Mood disorders Newsletter Women in Science

From science to yoga — and back to science

After initial studies in science, Zeynep Knight-Celen opts for a life practicing and teaching yoga. Ten years later her interest in the workings of the mind rekindles her scientific curiosity...
Read More
A psychologist in a clinical research team
Mood disorders Newsletter

A psychologist in a clinical research team

Ryan Murray’s work within Synapsy WP#5 focuses on measuring brain reactivity to and recovery from psychosocial stress within clinical patients and healthy controls. He talked to us about his role...
Read More
Genetics to stratify the WP#5 cohort
Mood disorders Newsletter

Genetics to stratify the WP#5 cohort

Giorgio Pistis is profiling polygenic scores to understand whether genetic risks associated with particular pathophysiological pathways are higher in specific sub-groups of patients of the mood disorder cohort. Synapsy met...
Read More
Editorial – by Camilla Bellone
Mood disorders Newsletter

Editorial – by Camilla Bellone

2020 has been a challenging year for the Synapsy community and for the whole society. The impact of the COVID-19 pandemic on health, economy and employment has been unprecedented worldwide....
Read More
Zoom Conference on Equal opportunity with Prof. Dr. Tom Welton
Equal opportunity

Zoom Conference on Equal opportunity with Prof. Dr. Tom Welton

A open conference organized by NCCR Molecular Systems with Prof. Dr. Tom Welton on the topic "Scientific Excellence and Equality – a Contradiction?" will take place November 4th, 13:30-15:10 on...
Read More
Johannes Gräff promoted to associate professor
NEWS Nomination

Johannes Gräff promoted to associate professor

Prof. Johannes Gräff, Synapsy principal investigator, has been promoted to Associate Professor of Life Sciences at the School of Life Sciences at EPFL. At its meeting of 23/24 September 2020...
Read More
Obsessive Compulsive Disorders: How to treat OCD?
Mood disorders

Obsessive Compulsive Disorders: How to treat OCD?

The fourth most common psychiatric illness, OCD affects between 2 and 3% of the population. Obsessive compulsive disorder, called OCD, is a psychological disorder. It is characterized by distressing obsessions...
Read More
Editorial by Camilla Bellone, Carmen Sandi and Philippe Conus
Newsletter

Editorial by Camilla Bellone, Carmen Sandi and Philippe Conus

Dear Colleagues, It is with a profound grief that we are writing the editorial of this issue of the NCCR Synapsy Newsletter. As you certainly all know, Alexandre Dayer, the...
Read More
Synapsy model imitated worldwide
Newsletter Portrait

Synapsy model imitated worldwide

The translational graduate program at the International Max-Planck Research School for Translational Psychiatry – which is similar to Synapsy’s – is used to teach physicians and researchers. Two PhD students...
Read More
Using genetics and sharing to study autism
Autism Spectrum Disorder Newsletter Portrait

Using genetics and sharing to study autism

French researcher Thomas Bourgeron is a pioneer in genetic research on autism. The professor was also our guest at the last Neurobiology of Mental Health conference. In this article, he...
Read More
What will the psychiatry of tomorrow look like?
Newsletter Portrait

What will the psychiatry of tomorrow look like?

A female student in medicine at the University of Geneva (who is keen to remain anonymous) dreams of a career in psychiatry. To achieve her goals, she is soaking up...
Read More
Confined planet: a challenge for women
NEWS Women in Science

Confined planet: a challenge for women

Following the WHO's announcement on the coronavirus pandemic, our planet entered several weeks of confinement. Since then, the scientific community has been studying the consequences of this health crisis, particularly...
Read More
Death of Prof. Alexandre Dayer, NCCR Synapsy director
NEWS

Death of Prof. Alexandre Dayer, NCCR Synapsy director

Dear members of the Synapsy community, It is with great sadness that I have to inform you of the tragic passing of our NCCR Synapsy Director, colleague and friend Alexandre....
Read More
Gliapharm completes a CHF 2 Million financing to advance its drug development program
KTT NEWS

Gliapharm completes a CHF 2 Million financing to advance its drug development program

GliaPharm SA has completed a CHF 2 million financing. The company is initially focusing on an orphan neurological disease caused by a deficiency in brain metabolism that affects more than...
Read More
Optimus Agora Prize for Carmen Sandi and Dominique de Quervain
Award Mood disorders NEWS

Optimus Agora Prize for Carmen Sandi and Dominique de Quervain

Dominique de Quervain and Carmen Sandi are being awarded Optimus Agora Prize. Their project “Stress” encourages interaction with the public. Stress is part of everyday life. Better understanding it, and...
Read More
covidout.ch: maintaining mental health and developing coping skills
Mood disorders NEWS

covidout.ch: maintaining mental health and developing coping skills

The objective of this new web app, designed by caregivers and researchers, is to help people with temporary/reactional or chronic psychological suffering to find coping strategies to better cope with...
Read More
1 2 3 13